Agilent Technologies (NYSE:A – Free Report) had its target price hoisted by The Goldman Sachs Group from $155.00 to $175.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has a buy rating on the medical research company’s stock.
Several other equities analysts have also weighed in on the stock. Barclays upped their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Thursday. Royal Bank Of Canada raised their price objective on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday. Morgan Stanley boosted their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Finally, Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $170.33.
Agilent Technologies Stock Performance
Agilent Technologies (NYSE:A – Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. Agilent Technologies’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts forecast that Agilent Technologies will post 6.2 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. California State Teachers Retirement System raised its position in Agilent Technologies by 12,343.3% in the 2nd quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company’s stock valued at $7,249,471,000 after buying an additional 54,138,451 shares during the last quarter. State Street Corp boosted its holdings in Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after acquiring an additional 241,029 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after acquiring an additional 198,253 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Finally, Deutsche Bank AG grew its stake in shares of Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter.
Agilent Technologies News Summary
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
- Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
- Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
